| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.49 | 7e-05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |